Sp09
Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China
Lv Lulu
Juventas Cell Therapy Ltd
Lido
1112
Vezesque se leu este artigo
490
Total PDF
622
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 31 | 14 | 45 |
| 2025 5 | 42 | 8 | 50 |
| 2025 4 | 40 | 19 | 59 |
| 2025 3 | 38 | 12 | 50 |
| 2025 2 | 31 | 21 | 52 |
| 2025 1 | 38 | 26 | 64 |
| 2024 12 | 28 | 24 | 52 |
| 2024 11 | 30 | 18 | 48 |
| 2024 10 | 18 | 21 | 39 |
| 2024 9 | 27 | 13 | 40 |
| 2024 8 | 24 | 25 | 49 |
| 2024 7 | 24 | 19 | 43 |
| 2024 6 | 26 | 27 | 53 |
| 2024 5 | 28 | 30 | 58 |
| 2024 4 | 25 | 19 | 44 |
| 2024 3 | 26 | 26 | 52 |
| 2024 2 | 23 | 33 | 56 |
| 2024 1 | 45 | 32 | 77 |
| 2023 12 | 23 | 18 | 41 |
| 2023 11 | 32 | 45 | 77 |
| 2023 10 | 23 | 40 | 63 |
Mostrar tudo
